The Patent Finder

Addex Pharmaceuticals S.A.

Also on record
Records under this name other than the patents Addex Pharmaceuticals S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Addex Pharmaceuticals S.A.

PatentTitleStatus Expires Confidence
US 9,114,1381′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,674,106Alkynyl derivatives as modulators of metabotropic glutamate receptors
Formerly held
Term ended
Ended no later than Jun 17, 2025 · From the USPTO record
Term endedEnded no later than Jun 17, 2025From the USPTO record
US 8,883,826Alkynyl derivatives as modulators of metabotropic glutamate receptors
Formerly held
Term ended
Term ended Jun 17, 2025 · From the USPTO record
Term endedTerm ended Jun 17, 2025From the USPTO record
US 8,399,493Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors
Formerly held
Lapsed on the fee record
Ended Mar 19, 2025 · From the USPTO record
Lapsed on the fee recordEnded Mar 19, 2025From the USPTO record
US 8,748,6211,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
Formerly held
Lapsed on the fee record
Ended Jun 10, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jun 10, 2022From the USPTO record
US 8,722,8941,3-disubstituted-4-phenyl-1H-pyridin-2-ones
Formerly held
Lapsed on the fee record
Ended May 13, 2022 · From the USPTO record
Lapsed on the fee recordEnded May 13, 2022From the USPTO record
US 8,252,9371,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
Formerly held
Lapsed on the fee record
Ended Aug 28, 2020 · From the USPTO record
Lapsed on the fee recordEnded Aug 28, 2020From the USPTO record
US 7,205,411Aminopyridine derivatives as mGluR5 antagonists
Formerly held
Lapsed on the fee record
Ended Apr 17, 2015 · From the USPTO record
Lapsed on the fee recordEnded Apr 17, 2015From the USPTO record
US 7,834,035Allosteric modulators of metabotropic glutamate receptors
Formerly held
Lapsed on the fee record
Ended Nov 16, 2014 · From the USPTO record
Lapsed on the fee recordEnded Nov 16, 2014From the USPTO record
US 6,211,173Use of 2,3,4,5-tetrahydro-1H-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
Formerly held
Lapsed on the fee record
Ended Apr 3, 2013 · From the USPTO record
Lapsed on the fee recordEnded Apr 3, 2013From the USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited